Envoy Medical Inc.

COCH | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.72

+$0.01 (+1.34%)

Sep 22, 2026, 10:51 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	51K	39K	75K	42K	78K	46K	42K	56K	68K	59K	95K	80K	63K	78K	20K	57K	59K	101K	n/a	n/a	n/a	n/a
Cost of Revenue	278K	313K	211K	203K	234K	226K	157K	187K	245K	153K	234K	189K	162K	175K	151K	106K	218K	213K	n/a	n/a	n/a	n/a
Gross Profit	-227K	-274K	-136K	-161K	-156K	-180K	-115K	-131K	-177K	-94K	-139K	-109K	-99K	-97K	-131K	-49K	-159K	-112K	n/a	n/a	n/a	n/a
Operating Income	-5.57M	-5.96M	-6.39M	-5.71M	-5.07M	-5.11M	-4.52M	-4.97M	-4.86M	-4.9M	-6.72M	-3.39M	-4.48M	-3.77M	-2.91M	-1.8M	-2.19M	-1.81M	-963.91K	-2.99M	-1.07M	-966.28K
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	5.47K	15.38K	7.84K
Pretax Income	-5.98M	-4.35M	-6.59M	-6.48M	-5.69M	-5M	-4.62M	-5.96M	-3.95M	-6.27M	-4.9M	1.56M	-13.25M	-13.25M	-11.48M	-1.34M	-1.24M	-1.87M	-4.72M	5.57M	371.14K	-1.47M
Net Income	-5.98M	-4.35M	-6.59M	-6.48M	-5.69M	-5M	-4.62M	-5.96M	-3.95M	-6.27M	-4.9M	1.56M	-13.25M	-13.25M	-11.48M	-1.34M	-1.24M	-1.87M	-4.72M	5.57M	371.14K	-1.47M
Selling & General & Admin	2.21M	2.04M	1.7M	2.85M	2.43M	2.18M	1.94M	2.09M	2.09M	2.44M	3.53M	1.43M	2.23M	1.75M	1.33M	812K	674K	652K	963.91K	2.99M	1.07M	966.28K
Research & Development	3.13M	3.64M	4.55M	2.7M	2.49M	2.75M	2.47M	2.76M	2.59M	2.36M	3.06M	1.85M	2.15M	1.93M	1.44M	935K	1.36M	1.05M	n/a	n/a	n/a	n/a
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	5.34M	5.69M	6.25M	5.55M	4.91M	4.93M	4.41M	4.84M	4.68M	4.8M	6.58M	3.28M	4.38M	3.67M	2.78M	1.75M	2.04M	1.7M	963.91K	2.99M	1.07M	966.28K
Interest Expense	n/a	n/a	n/a	471K	624K	495K	384K	264K	132K	36K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	5.47K	n/a	n/a
Selling & Marketing Expenses	181K	164K	96K	405K	361K	358K	518K	394K	497K	325K	513K	399K	383K	371K	885K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	5.62M	6M	6.46M	5.75M	5.15M	5.15M	4.57M	5.03M	4.93M	4.96M	6.82M	3.47M	4.54M	3.85M	2.93M	1.85M	2.25M	1.91M	963.91K	2.99M	1.07M	966.28K
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	104.04M	68.93M	46.1M	21.85M	21.38M	21.33M	21.33M	19.62M	19.6M	18.6M	19.6M	19.55M	19.55M	42.52M	53.13M	10.21M	53.13M	53.13M	53.13M	53.13M	53.13M	42M
Shares Outstanding (Diluted)	104.04M	68.93M	46.1M	21.85M	19.6M	21.33M	21.33M	19.62M	19.6M	18.6M	19.6M	19.55M	19.55M	42.52M	53.13M	11.22M	53.13M	53.13M	53.13M	53.13M	53.13M	42M
EPS (Basic)	-0.07	-0.08	-0.17	-0.35	-0.32	-0.29	-0.36	-0.37	-0.27	-0.41	-0.25	0.07	-0.68	-1.30	-0.22	-0.13	-0.17	-0.04	-0.09	0.10	0.01	-0.04
EPS (Diluted)	-0.07	-0.08	-0.17	-0.35	-0.32	-0.29	-0.36	-0.37	-0.27	-0.41	-0.25	0.07	-0.68	-1.30	-0.22	-0.12	-0.15	-0.04	-0.09	0.10	0.01	-0.04
EBITDA	-5.91M	-4.28M	-6.51M	-5.94M	-4.98M	-4.44M	-4.19M	-5.65M	-3.77M	-6.2M	-4.85M	1.59M	-13.22M	-13.23M	-11.45M	-1.32M	-1.22M	-1.86M	-4.72M	14.13M	1.81M	-1.47M
EBIT	-5.98M	-4.35M	-6.59M	-6.01M	-5.07M	-4.5M	-4.23M	-5.7M	-3.82M	-6.23M	-4.9M	1.56M	-13.25M	-13.25M	-11.48M	-1.34M	-1.24M	-1.87M	-4.72M	5.57M	371.14K	-1.47M
Depreciation & Amortization	74K	73K	80K	76K	85K	61K	48K	49K	42K	34K	48K	29K	29K	27K	26K	22K	14K	13K	n/a	8.56M	1.44M	n/a